HomeOMND • CNSX
add
Optimind Pharma Corp
Previous close
$0.010
Year range
$0.0050 - $0.010
Market cap
1.10M CAD
Avg Volume
5.60K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Feb 2025info | Y/Y change |
|---|---|---|
Revenue | 34.70K | 25.45% |
Operating expense | 43.44K | -72.93% |
Net income | -26.70K | 96.22% |
Net profit margin | -76.96 | 96.98% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Feb 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 83.77K | 191.94% |
Total assets | 200.13K | -15.97% |
Total liabilities | 274.96K | -25.12% |
Total equity | -74.83K | — |
Shares outstanding | 102.79M | — |
Price to book | ∞ | — |
Return on assets | -26.42% | — |
Return on capital | -85.06% | — |
Cash Flow
Net change in cash
| (CAD) | Feb 2025info | Y/Y change |
|---|---|---|
Net income | -26.70K | 96.22% |
Cash from operations | -18.80K | -492.28% |
Cash from investing | — | — |
Cash from financing | 0.00 | — |
Net change in cash | -18.80K | -455.21% |
Free cash flow | -5.74K | -113.33% |
About
Founded
2008
Headquarters
Website
